Finance Process Improvement Analyst

Job Description
Financial Analyst
Vaxxinova US is seeking an individual to join our finance team as a Financial Analyst in Willmar or Worthington, Minnesota. The Financial Analyst will work closely with all areas of the business and act as a Business Partner. They will help bring visibility to the business through the creation of models and dashboards while also assisting in the creation of the budget.

Partner with various functions to align operational metrics with financial outcomes
Utilize Power BI to translate complex financial data sets in easily understood dashboards
Review and assist in the implementation of sales, operations, and inventory KPIs
Contribute to process improvements and documentation of procedures
Support internal and external audit requests
Solid understanding of general ledger coding, inventory costing, and production accounting
Familiarity with cost center accounting and production workflows in ERP systems
Highly proficient with accounting software (ERP systems)
Advanced proficiency in Power BI and writing complex, optimized DAX formulas
Proficient in MS Office, specifically Microsoft Excel
Ability to use sound judgement to determine accuracy and completeness of financial data
Bachelor’s degree in finance, accounting, or related field
This position is a day shift position with primary hours between 7:30 AM-5:00 PM Monday through Friday with potential overtime depending on production schedules.

We are proud to offer a generous benefit package in addition to competitive compensation, including employer contributions towards medical, dental and vision premiums. Medical
~ Dental
~ Health Savings Account with company contribution
~9 Paid holidays
~ Company paid short and long-term disability
~ Company paid life insurance
~ Our focus is on livestock including cattle, poultry, swine and aqua. Vaxxinova US, formerly known as Epitopix and Newport Laboratories, is the US operating unit of Vaxxinova International, headquartered in the Netherlands.

Vaxxinova US has a strong market presence making autogenous vaccines for cattle, swine, and poultry as well as a state-of-the-art diagnostic laboratory. Vaxxinova currently has facilities in fourteen countries including Brazil, Canada, Chile, Colombia, Croatia, Italy, Germany, Japan, Jordan, Norway, South Africa, Thailand, the USA, and the Netherlands. The EW Group specializes in animal genetics, animal nutrition and animal health, operates in over 100 countries and records consistent international growth.

Vaxxinova US does not accept unsolicited CVs from recruiters or employment agencies in response to job postings on social media or Vaxxinova US websites. Vaxxinova US explicitly reserves the right to hire those candidate(s) without any financial obligation to the recruiter or agency. Phone calls or emails from recruiters or employment agencies are not appreciated.